151 related articles for article (PubMed ID: 21142218)
1. Potent inhibitor design against H1N1 swine influenza: structure-based and molecular dynamics analysis for M2 inhibitors from traditional Chinese medicine database.
Lin CH; Chang TT; Sun MF; Chen HY; Tsai FJ; Chang KL; Fisher M; Chen CY
J Biomol Struct Dyn; 2011 Feb; 28(4):471-82. PubMed ID: 21142218
[TBL] [Abstract][Full Text] [Related]
2. High performance screening, structural and molecular dynamics analysis to identify H1 inhibitors from TCM Database@Taiwan.
Chang SS; Huang HJ; Chen CY
Mol Biosyst; 2011 Dec; 7(12):3366-74. PubMed ID: 22012120
[TBL] [Abstract][Full Text] [Related]
3. Screening from the world's largest TCM database against H1N1 virus.
Chang TT; Sun MF; Chen HY; Tsai FJ; Fisher M; Lin JG; Chen CY
J Biomol Struct Dyn; 2011 Apr; 28(5):773-86. PubMed ID: 21294588
[TBL] [Abstract][Full Text] [Related]
4. Insights from investigating the interactions of adamantane-based drugs with the M2 proton channel from the H1N1 swine virus.
Wang JF; Wei DQ; Chou KC
Biochem Biophys Res Commun; 2009 Oct; 388(2):413-7. PubMed ID: 19665993
[TBL] [Abstract][Full Text] [Related]
5. Designing inhibitors of M2 proton channel against H1N1 swine influenza virus.
Du QS; Huang RB; Wang SQ; Chou KC
PLoS One; 2010 Feb; 5(2):e9388. PubMed ID: 20186344
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.
Rungrotmongkol T; Intharathep P; Malaisree M; Nunthaboot N; Kaiyawet N; Sompornpisut P; Payungporn S; Poovorawan Y; Hannongbua S
Biochem Biophys Res Commun; 2009 Jul; 385(3):390-4. PubMed ID: 19463784
[TBL] [Abstract][Full Text] [Related]
7. Ligand-based dual target drug design for H1N1: swine flu--a preliminary first study.
Chen CY; Chang YH; Bau DT; Huang HJ; Tsai FJ; Tsai CH; Chen CY
J Biomol Struct Dyn; 2009 Oct; 27(2):171-8. PubMed ID: 19583443
[TBL] [Abstract][Full Text] [Related]
8. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
Moorthy NS; Poongavanam V; Pratheepa V
Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
[TBL] [Abstract][Full Text] [Related]
9. Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus.
Woods CJ; Malaisree M; Pattarapongdilok N; Sompornpisut P; Hannongbua S; Mulholland AJ
Biochemistry; 2012 May; 51(21):4364-75. PubMed ID: 22574858
[TBL] [Abstract][Full Text] [Related]
10. Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine.
Chang SS; Huang HJ; Chen CY
PLoS Comput Biol; 2011 Dec; 7(12):e1002315. PubMed ID: 22215997
[TBL] [Abstract][Full Text] [Related]
11. Structural and energetic analysis of drug inhibition of the influenza A M2 proton channel.
Gu RX; Liu LA; Wei DQ
Trends Pharmacol Sci; 2013 Oct; 34(10):571-80. PubMed ID: 24011996
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the anti-neuraminidase activity of the traditional Chinese medicines and determination of the anti-influenza A virus effects of the neuraminidase inhibitory TCMs in vitro and in vivo.
Tian L; Wang Z; Wu H; Wang S; Wang Y; Wang Y; Xu J; Wang L; Qi F; Fang M; Yu D; Fang X
J Ethnopharmacol; 2011 Sep; 137(1):534-42. PubMed ID: 21699971
[TBL] [Abstract][Full Text] [Related]
13. Discovery of highly potent agents against influenza A virus.
Zhao X; Li C; Zeng S; Hu W
Eur J Med Chem; 2011 Jan; 46(1):52-7. PubMed ID: 21094565
[TBL] [Abstract][Full Text] [Related]
14. Anti-influenza agents from Traditional Chinese Medicine.
Ge H; Wang YF; Xu J; Gu Q; Liu HB; Xiao PG; Zhou J; Liu Y; Yang Z; Su H
Nat Prod Rep; 2010 Jan; 27(12):1758-80. PubMed ID: 20941447
[No Abstract] [Full Text] [Related]
15. Differential patterns of amantadine-resistance in influenza A (H3N2) and (H1N1) isolates in Toronto, Canada.
Higgins RR; Eshaghi A; Burton L; Mazzulli T; Drews SJ
J Clin Virol; 2009 Jan; 44(1):91-3. PubMed ID: 19019729
[TBL] [Abstract][Full Text] [Related]
16. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
[TBL] [Abstract][Full Text] [Related]
17. Computational screen and experimental validation of anti-influenza effects of quercetin and chlorogenic acid from traditional Chinese medicine.
Liu Z; Zhao J; Li W; Shen L; Huang S; Tang J; Duan J; Fang F; Huang Y; Chang H; Chen Z; Zhang R
Sci Rep; 2016 Jan; 6():19095. PubMed ID: 26754609
[TBL] [Abstract][Full Text] [Related]
18. Discovery of potential M2 channel inhibitors based on the amantadine scaffold via virtual screening and pharmacophore modeling.
Tran L; Choi SB; Al-Najjar BO; Yusuf M; Wahab HA; Le L
Molecules; 2011 Dec; 16(12):10227-55. PubMed ID: 22158591
[TBL] [Abstract][Full Text] [Related]
19. Virtual screening of potential inhibitors from TCM for the CPSF30 binding site on the NS1A protein of influenza A virus.
Ai H; Zhang L; Chang AK; Wei H; Che Y; Liu H
J Mol Model; 2014 Mar; 20(3):2142. PubMed ID: 24562912
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors.
Zhao X; Jie Y; Rosenberg MR; Wan J; Zeng S; Cui W; Xiao Y; Li Z; Tu Z; Casarotto MG; Hu W
Antiviral Res; 2012 Nov; 96(2):91-9. PubMed ID: 22982118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
